Probiotic L. reuteri Treatment Prevents Bone Loss in a Menopausal Ovariectomized Mouse Model

Journal of Cellular Physiology

Volumn 229, Issue 11, 2014, Pages 1822-1830

  Britton, Robert A ^a   Irwin, Regina ^b   Quach, Darin ^a   Schaefer, Laura ^a   Zhang, Jing ^b   Lee, Taehyung ^b   Parameswaran, Narayanan ^b   Mccabe, Laura R ^b,c  

^a Department of Microbiology and Molecular Genetics Michigan State University ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; LACTOBACILLUS REUTERI; MENOPAUSE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MORPHOMETRICS; MOUSE; MOUSE MODEL; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY-INDUCED OSTEOPOROSIS; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; FLOW CYTOMETRY; LACTOBACILLUS; MENOPAUSE; MICE; MICE, INBRED BALB C; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OVARIECTOMY; PRINCIPAL COMPONENT ANALYSIS; PROBIOTICS; RANK LIGAND; SPINE;

EID: 84904893893     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24636     Document Type: Article

References (51)

1. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ. 2005. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. The Am J Clin Nutr 82:471-476.
2. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-341.
3. Backhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, Versalovic J, Young V, Finlay BB. 2012. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12:611-622.
4. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer WG. 2005. Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res 20:1085-1092.
5. Chao A. 1984. Nonparametric-estimation of the number of classes in a population. Scand J Stat 11:265-270.
6. Chao A, Lee SM. 1992. Estimating the number of classes via sample coverage. J Am Stat Assoc 87:210-217.
7. Coxam V. 2007. Current data with inulin-type fructans and calcium, targeting bone health in adults. J Nutr 137:2527S-2533S.
8. Fukata M, Breglio K, Chen A, Vamadevan AS, Goo T, Hsu D, Conduah D, Xu R, Abreu MT. 2008. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol 180:1886-1894.
9. Harris L, Senagore P, Young VB, McCabe LR. 2009. Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest liver physiol 296:G1020-G1029.
10. Jadlowiec J, Koch H, Zhang X, Campbell PG, Seyedain M, Sfeir C. 2004. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J Biol Chem 279:53323-53330.
11. Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC. 1998. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest 101:1942-1950.
12. Jolliff JS, Mahan DC. 2012. Effect of dietary inulin and phytase on mineral digestibility and tissue retention in weanling and growing swine. J Anim Sci 90:3012-3022.
13. Kimoto-Nira H, Suzuki C, Kobayashi M, Sasaki K, Kurisaki J, Mizumachi K. 2007. Anti-ageing effect of a lactococcal strain: Analysis using senescence-accelerated mice. Br J Nutr 98:1178-1186.
14. Kuhbacher T, Ott SJ, Helwig U, Mimura T, Rizzello F, Kleessen B, Gionchetti P, Blaut M, Campieri M, Folsch UR, Kamm MA, Schreiber S. 2006. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55:833-841.
15. Lee T, Lee E, Irwin R, Lucas PC, McCabe LR, Parameswaran N. 2013. Beta-arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol 182:1114-1123.
16. Lemon KP, Armitage GC, Relman DA, Fischbach MA. 2012. Microbiota-targeted therapies: an ecological perspective. Sci Transl Med 4:137rv135.
17. Li JY, Tawfeek H, Bedi B, Yang X, Adams J, Gao KY, Zayzafoon M, Weitzmann MN, Pacifici R. 2011. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci USA 108:768-773.
18. Manolagas SC. 2010. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266-300.
19. McCabe LR, Irwin R, Schaefer L, Britton RA. 2013. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol 228:1793-1798.
20. McNamara LM. 2010. Perspective on post-menopausal osteoporosis: Establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J R Soc Interface 7:353-372.
21. Motyl K, McCabe LR. 2009. Streptozotocin, type I diabetes severity and bone. Biol Proced Online.
22. Mutus R, Kocabagli N, Alp M, Acar N, Eren M, Gezen SS. 2006. The effect of dietary probiotic supplementation on tibial bone characteristics and strength in broilers. Poultry science 85:1621-1625.
23. National-Osteoporosis-Foundation 2009. National Osteoporosis Foundation National Web Site. http://www.nof.org/.
24. Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. 2008. Diversity of human vaginal bacterial communities and associations withclinically defined bacterial vaginosis. Appl Environ Microbiol 74:4898-4909.
25. Pacifici R. 2012. Role of T cells in ovariectomy induced bone loss-revisited. J Bone Miner Res 27:231-239.
26. Patial S, Shahi S, Saini Y, Lee T, Packiriswamy N, Appledorn DM, Lapres JJ, Amalfitano A, Parameswaran N. 2011. G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFkappaB activation in primary macrophages and modulates inflammation in vivo in mice. J Cell Physiol 226:1323-1333.
27. Reuter G. 2001. The Lactobacillus and Bifidobacterium microflora of the human intestine: Composition and succession. Curr Issues Intest Microbiol 2:43-53.
28. Riggs BL, Khosla S, Melton LJ III. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302.
29. Roberfroid MB, Cumps J, Devogelaer JP. 2002. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 132:3599-3602.
30. Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-594.
31. Schaefer L, Auchtung TA, Hermans KE, Whitehead D, Borhan B, Britton RA. 2010. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology 156:1589-1599.
32. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537-7541.
33. Scholz-Ahrens KE, Schrezenmeir J. 2007. Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr 137:2513S-2523S.
34. Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T. 1997. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 24:399-404.
35. Sjogren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Backhed F, Ohlsson C. 2012. The gut microbiota regulates bone mass in mice. J Bone Miner Res 27:1357-1367.
36. Teitelbaum SL. 2007. Osteoclasts: what do they do and how do they do it? Am J Pathol 170:427-435.
37. The ESHRE Capri Workshop Group 2010. Bone fractures after menopause. Hum Reprod Update 16:761-773.
38. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J. 2012. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLOS One 7:e31951.
39. Thomas DW, Greer FR. 2010. Probiotics and prebiotics in pediatrics. Pediatrics 126:1217-1231.
40. Tubelius P, Stan V, Zachrisson A. 2005. Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study. Environ Health 4:25.
41. Vaarala O, Atkinson MA, Neu J. 2008. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555-2562.
42. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. 2004. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70:1176-1181.
43. Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73:5261-5267.
44. Weaver CM, Martin BR, Nakatsu CH, Armstrong AP, Clavijo A, McCabe LD, McCabe GP, Duignan S, Schoterman MH, van den Heuvel EG. 2011. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J Agric Food Chem 59:6501-6510.
45. Weizman Z, Asli G, Alsheikh A. 2005. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics 115:5-9.
46. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109-1113.
47. Whelan K, Quigley EM. 2013. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 29:184-189.
48. Yan F, Polk DB. 2011. Probiotics and immune health. Curr Opin Gastroenterol 27:496-501.
49. Yang LC, Wu JB, Lu TJ, Lin WC. 2012. The prebiotic effect of Anoectochilus formosanus and its consequences on bone health. Br J Nutr 1-10.
50. Yoo J, Tcheurekdjian H, Lynch SV, Cabana M, Boushey HA. 2007. Microbial manipulation of immune function for asthma prevention: Inferences from clinical trials. Proc Am Thorac Soc 4:277-282.
51. Zhao S, Zhang YK, Harris S, Ahuja SS, Bonewald LF. 2002. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res 17:2068-2079.